Dong Jincai, Gu Wen, Yang Xingxin, Zeng Linxi, Wang Xi, Mu Jiankang, Wang Yanfang, Li Fengjiao, Yang Min, Yu Jie
Yunnan Key Laboratory of Southern Medicine Utilization, College of Pharmaceutical Science, Yunnan University of Chinese Medicine, Kunming, China.
Chenggong Hospital of Kunming Yan'an Hospital, Kunming, China.
Front Pharmacol. 2021 Oct 27;12:740528. doi: 10.3389/fphar.2021.740528. eCollection 2021.
is a medicinal herb used in various traditional Chinese medicine formulations. The polysaccharide fraction of can reduce insulin resistance and restore the gut microbiota in a rat model of aberrant lipid metabolism by down regulating miR-122. The aim of this study was to further elucidate the effect of on lipid metabolism, and the roles of specific miRNAs and the gut microbiota. administration significantly altered the abundance of 29 gut microbes and 27 differentially expressed miRNAs (DEMs). Several aberrantly expressed miRNAs closely related to lipid metabolism were identified, of which some were associated with specific gut microbiota. MiR-484 in particular was identified as the core factor involved in the therapeutic effects of . We hypothesize that the miR-484- axis acts as an important bridge hub that connects the entire miRNA-gut microbiota network. In addition, we observed that and correlated significantly with several miRNAs, including miR-484, miR-122-5p, miR-184 and miR-378b. alleviates lipid metabolism disorder by targeting the network of key miRNAs and the gut microbiota.
是一种用于多种中药配方的草药。其多糖部分可通过下调miR - 122来降低胰岛素抵抗,并在异常脂质代谢大鼠模型中恢复肠道微生物群。本研究的目的是进一步阐明其对脂质代谢的影响,以及特定miRNA和肠道微生物群的作用。给药显著改变了29种肠道微生物的丰度和27种差异表达miRNA(DEM)。鉴定出了几种与脂质代谢密切相关的异常表达miRNA,其中一些与特定肠道微生物群有关。特别是miR - 484被确定为参与其治疗作用的核心因子。我们假设miR - 484轴作为连接整个miRNA - 肠道微生物群网络的重要桥梁枢纽。此外,我们观察到与几种miRNA显著相关,包括miR - 484、miR - 122 - 5p、miR - 184和miR - 378b。通过靶向关键miRNA和肠道微生物群网络来减轻脂质代谢紊乱。